• • Company Values
  • Management Team
  • Corporate Quality
  • News & Events
    • Press Releases
    • Events
    • Press Contacts
• • Invader
  • Invader Plus
  • InPlex
  • qInvader
• • IVD Products
    • InPlex CF
    • UGT1A1
  • ASRs
    • Factor V
    • Factor II
    • MTHFR 677
    • MTHFR 1298
    • HPV Reagents
    • HPV 16/18
    • HCVg
    • CYP2C9*2 & CYP2C9*3
    • VKORC1
    • Others
  • Universal Invader
  • Product Pipeline
• • qInvader
  • AgBio
• • Stock Quote
  • Stock Chart
  • Historical Price Lookup
  • Corporate Governance
    • Highlights
    • Committee Composition
  • Investor Events
    • Upcoming Events
    • Past Events
  • FAQ
  • Information Request
  • SEC Filings
  • E-Mail Alerts
• • Search Opportunities
  • Benefits
  • Locations
  • Equal Opportunity Statement

• IVD Products
• ASRs
• Universal Invader
• Product Pipeline

Clinical Customers

Third Wave currently markets IVD tests for Cystic Fibrosis and UTG1A1. In addition to these IVD products, Third Wave has a broad menu of Analyte Specific Reagents currently used by over 210 clinical laboratories in the United States. Third Wave's future includes FDA submissions for High-Risk HPV Screening and 16/18 Genotyping tests as well as continued expansion of our test menu through development of new ASRs.

*Analyte Specific Reagent. Analytical and performance characteristics are not established.